Puru Nanjappa

1.4k total citations
23 papers, 1.0k citations indexed

About

Puru Nanjappa is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Puru Nanjappa has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Hematology. Recurrent topics in Puru Nanjappa's work include Multiple Myeloma Research and Treatments (11 papers), DNA Repair Mechanisms (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Puru Nanjappa is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), DNA Repair Mechanisms (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Puru Nanjappa collaborates with scholars based in United States, Italy and China. Puru Nanjappa's co-authors include Nikhil C. Munshi, Mariateresa Fulciniti, Rao Prabhala, Kenneth C. Anderson, Yu‐Tzu Tai, Teru Hideshima, Pierfrancesco Tassone, Dharminder Chauhan, Nipun Patel and Zhenxin Shen and has published in prestigious journals such as Blood, Oncogene and Clinical Cancer Research.

In The Last Decade

Puru Nanjappa

23 papers receiving 1.0k citations

Peers

Countries citing papers authored by Puru Nanjappa

Since Specialization

Citations

This map shows the geographic impact of Puru Nanjappa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Puru Nanjappa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Puru Nanjappa more than expected).

Fields of papers citing papers by Puru Nanjappa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Puru Nanjappa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Puru Nanjappa. The network helps show where Puru Nanjappa may publish in the future.

Co-authorship network of co-authors of Puru Nanjappa

This figure shows the co-authorship network connecting the top 25 collaborators of Puru Nanjappa. A scholar is included among the top collaborators of Puru Nanjappa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Puru Nanjappa. Puru Nanjappa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Role of apurinic/apyrimidinic nucleases in the regulation of homologous recombination in myeloma: mechanisms and translational significance 2018 ·Blood Cancer Journal ·Subodh Kumar, Srikanth Talluri, Jagannath Pal, Xiaoli Yuan, Renquan Lu, Puru Nanjappa, Mehmet Samur, Nikhil C. Munshi, Masood A. Shammas	37
2	Bone Marrow Microenvironment Induces Genomic Instability and Enables Clonal Evolution in Multiple Myeloma 2017 ·Blood ·Tommaso Perini, Raphaël Szalat, Mariateresa Fulciniti, Mehmet Samur, Michael Lopez, Puru Nanjappa, Kenneth Wen, Na Li, Yan Xu, Yu‐Tzu Tai, Masood A. Shammas, Kenneth C. Anderson, Fabio Ciceri, Nikhil Munshi	1
3	Apobec Family of Proteins Mediate Genomic Changes in Multiple Myeloma By Inducing DNA Damage and C>T Mutations 2017 ·Blood ·Srikanth Talluri, Mehmet Samur, Leutz Buon, Puru Nanjappa, (unknown), Masood A. Shammas, Nikhil C. Munshi	1
4	Ongoing Spontaneous DNA Damage and the Role of Aberrant Epigenome in Multiple Myeloma 2014 ·Blood ·Μαρία Γκοτζαμανίδου, Masood A. Shammas, Vassilis L. Souliotis, Weihua Song, Jagannath Pal, Puru Nanjappa, Naim U. Rashid, Kenneth C. Anderson, Meletios Α. Dimopoulos, James E. Bradner, Nikhil C. Munshi	1
5	Elevated APE1 Mediates Dysregulation of Homologous Recombination in Myeloma: Mechanisms and Translational Significance 2014 ·Blood ·Subodh Kumar, Μαρία Γκοτζαμανίδου, Jagannath Pal, Renquan Lu, Puru Nanjappa, Jialan Shi, Masood A. Shammas, Nikhil C. Munshi	3
6	Dysregulation of SHFM1, a Novel Target for Prevention of Genomic Instability in Myeloma, Is Associated with Epigenetic Changes at Specific CpG Sites 2014 ·Blood ·Masood A. Shammas, Subodh Kumar, Jagannath Pal, Puru Nanjappa, (unknown), Μαρία Γκοτζαμανίδου, Jialan Shi, Nikhil Munshi	1
7	Targeting homologous recombination and telomerase in Barrett’s adenocarcinoma: impact on telomere maintenance, genomic instability and tumor growth 2013 ·Oncogene ·Rongzhu Lu, Jagannath Pal, Leutz Buon, Puru Nanjappa, Jialan Shi, Mariateresa Fulciniti, (unknown), Lin Guo, Manzhu Yu, Sergei Gryaznov, Nikhil C. Munshi, Masood A. Shammas	37
8	Targeting PI3K and RAD51 in Barrett's adenocarcinoma: impact on DNA damage checkpoints, expression profile and tumor growth. 2012 ·PubMed ·Jagannath Pal, Mariateresa Fulciniti, Puru Nanjappa, Leutz Buon, Yu‐Tzu Tai, Pierfrancesco Tassone, Nikhil C. Munshi, Masood A. Shammas	9
9	Significant Biological Role of Sp1 Transactivation in Multiple Myeloma 2011 ·Clinical Cancer Research ·Mariateresa Fulciniti, Samirkumar B. Amin, Puru Nanjappa, Scott J. Rodig, Rao Prabhala, Cheng Li, Stéphane Minvielle, Yu-Tzu Tai, Pierfrancesco Tassone, Hervé Avet‐Loiseau, Teru Hideshima, Kenneth C. Anderson, Nikhil C. Munshi	42
10	Anticancer Activity of a Broccoli Derivative, Sulforaphane, in Barrett Adenocarcinoma: Potential Use in Chemoprevention and as Adjuvant in Chemotherapy 2010 ·Translational Oncology ·Aamer Qazi, Jagannath Pal, Ma'in Y. Maitah, Mariateresa Fulciniti, Dheeraj Pelluru, Puru Nanjappa, (unknown), Ramesh B. Batchu, Madhu Prasad, Christopher S. Bryant, (unknown), Sergei Gryaznov, David G. Beer, Donald W. Weaver, Nikhil C. Munshi, Raj K. Goyal, Masood A. Shammas	69
11	Human Monoclonal Antibody Targeting IL-17A (AIN457) Down-Regulates MM Cell-Growth and Survival and Inhibits Osteoclast Development In Vitro and In Vivo: A Potential Novel Therapeutic Application In Myeloma 2010 ·Blood ·Rao Prabhala, Mariateresa Fulciniti, Dheeraj Pelluru, Puru Nanjappa, Christine Pai, (unknown), (unknown), Weihua Song, Constantine S. Mitsiades, Konstantinos Lefkimmiatis, Yu‐Tzu Tai, Irene M. Ghobrial, Paul G. Richardson, John Daley, Kenneth C. Anderson, Seth A. Ettenberg, Franco Di Padova, Nikhil C. Munshi	2
12	HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells 2010 ·Leukemia ·Wei Song, Y-T Tai, (unknown), Teru Hideshima, Dharminder Chauhan, Puru Nanjappa, Mark A. Exley, KC Anderson, (unknown)	84
13	Elevated IL-17 produced by Th17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma 2010 ·Blood ·Rao Prabhala, Dheeraj Pelluru, Mariateresa Fulciniti, Harsha Prabhala, Puru Nanjappa, Weihua Song, Christine Pai, Samirkumar B. Amin, Yu‐Tzu Tai, Paul G. Richardson, Irene M. Ghobrial, Steven P. Treon, John Daley, Kenneth C. Anderson, Jeffery L. Kutok, Nikhil C. Munshi	277
14	Significant Biological Role of Sp1 Transactivation in Myeloma: Potential Therapeutic Application. 2009 ·Blood ·Mariateresa Fulciniti, Teru Hideshima, Puru Nanjappa, Scott J. Rodig, Samirkumar B. Amin, Dheeraj Pelluru, Jagannath Pal, Rao Prabhala, Masood A. Shammas, Pierfrancesco Tassone, (unknown), Kenneth C. Anderson, Nikhil C. Munshi	1
15	Lack of Response to Vaccination in MGUS and Stable Myeloma. 2009 ·Blood ·Rao Prabhala, Yvonne A. Efebera, (unknown), Andrew Han, Dheeraj Pelluru, Puru Nanjappa, Samirkumar B. Amin, Christine Pai, Irene M. Ghobrial, Robert Schlossman, Jacob P. Laubach, Mariateresa Fulciniti, Paul G. Richardson, Kenneth C. Anderson, Nikhil C. Munshi	5
16	Gadolinium Containing Contrast Agent Promotes Multiple Myeloma Cell Growth: Implication for Clinical Use of MRI in Myeloma. 2009 ·Blood ·Mariateresa Fulciniti, Sundararaman Swaminathan, Puru Nanjappa, Samirkumar B. Amin, (unknown), Neriman Gökden, Kim M. Hiatt, Whitney A. High, Masood A. Shammas, Rao Prabhala, Teru Hideshima, Pierfrancesco Tassone, Kenneth C. Anderson, Sudhir V. Shah, Nikhil C. Munshi	2
17	A High-Affinity Fully Human Anti–IL-6 mAb, 1339, for the Treatment of Multiple Myeloma 2009 ·Clinical Cancer Research ·Mariateresa Fulciniti, Teru Hideshima, Claudine Vermot‐Desroches, Samantha Pozzi, Puru Nanjappa, Zhenxin Shen, Nipun Patel, Ernest Smith, Wei Wang, Rao Prabhala, Yu‐Tzu Tai, Pierfrancesco Tassone, Kenneth C. Anderson, Nikhil C. Munshi	90
18	Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma 2009 ·Blood ·Mariateresa Fulciniti, Pierfrancesco Tassone, Teru Hideshima, Sonia Vallet, Puru Nanjappa, Seth A. Ettenberg, Zhenxin Shen, Nipun Patel, Yu‐Tzu Tai, Dharminder Chauhan, Constantine S. Mitsiades, Rao Prabhala, Noopur Raje, Kenneth C. Anderson, David R. Stover, Nikhil C. Munshi	331
19	HDAC Inhibition by LBH589 Affects Phenotype and Function of Human Dendritic Cells. 2009 ·Blood ·Weihua Song, Yu‐Tzu Tai, Ze Tian, Teru Hideshima, Dharminder Chauhan, Puru Nanjappa, Mark A. Exley, Kenneth C. Anderson, Nikhil C. Munshi	1
20	TH17 Pathway Promotes Tumor Cell Growth and Suppresses Immune Function in Myeloma: Potential for Therapeutic Application 2008 ·Blood ·(unknown), Dheeraj Pelluru, Mariateresa Fulciniti, Puru Nanjappa, Harsha Prabhala, (unknown), Constantine S. Mitsiades, Yu-Tzu Tai, Irene M. Ghobrial, Paul L. Richardson, Konstantinos Lefkimmiatis, John Daley, Yvonne A. Efebera, Kenneth C. Anderson, Nikhil C. Munshi	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact